To Bioniche's Credit, not many 23 cent Biotechs could come out and publicly state that they have been approached by more than 30 potential marketing partners, for a successful P3 cancer drug, and trade lower than it did before the statement itself.
In a universe of inverse accomplishments this may be one of it's greatest successes.